Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Dec
10
2014
Legalization of Marijuana Raises Significant Questions and Issues for Employers Giordano, Halleran & Ciesla, P.C.
Jan
6
2020
Health Law Section Report – September-December 2019 Giordano, Halleran & Ciesla, P.C.
Sep
10
2013
New Jersey Court Bars Department of Environmental Protection’s (DEP) Reliance On “Guidance” For Stormwater Management Plans Giordano, Halleran & Ciesla, P.C.
Dec
5
2013
Remedial Investigation Deadline To Be Extended? Giordano, Halleran & Ciesla, P.C.
Jun
18
2019
Prescriptions From Outside the US Giordano, Halleran & Ciesla, P.C.
Jul
12
2023
First Of Its Kind With More To Follow: NJDEP Settlement Proposal Addresses PFAS Contamination Giordano, Halleran & Ciesla, P.C.
Jun
22
2013
Remediation Deadline Leads To Surge In Access Requests Giordano, Halleran & Ciesla, P.C.
Aug
24
2013
Doing The "One-Two" At the New Jersey Department of Environmental Protection Giordano, Halleran & Ciesla, P.C.
Oct
18
2017
New Jersey October 2, 2017 Healthcare Regulatory Developments Giordano, Halleran & Ciesla, P.C.
Sep
26
2013
New Jersey Department of Environmental Protection Stormwater Rules – NSPS Thrown Out Giordano, Halleran & Ciesla, P.C.
Nov
28
2018
November 2018 Regulatory Developments Giordano, Halleran & Ciesla, P.C.
Nov
17
2015
FDA Issues Final Produce Safety Rule Barnes & Thornburg LLP
Dec
2
2019
Illinois Legislature Clarifies Employer Liability Under Cannabis Act Barnes & Thornburg LLP
Jun
1
2016
FDA Serves Up New Nutrition Facts Label Barnes & Thornburg LLP
Jun
21
2016
FDA Issues Draft Guidance on Benefit-Risk Factors to Consider Regarding Medical Device Availability, Compliance, and Enforcement Barnes & Thornburg LLP
Feb
10
2017
New Drug Application Conflict Preemption Defense Gains Traction in Utts v. Bristol-Myers Squibb Co. Barnes & Thornburg LLP
Jul
13
2017
Post-BMS, Are Clinical-Trial Sites the New Hook for Hailing Out-of-State Pharmaceutical Defendants into Court? Barnes & Thornburg LLP
Mar
12
2014
EPA (Environmental Protection Agency) Extends Comment Deadline for Proposed Rule to Cap Carbon Emissions from New Power Plants Barnes & Thornburg LLP
Mar
24
2014
U.S. Food & Drug Administration (FDA) Issues Proposed Rule on Reclassifying Medical Devices Barnes & Thornburg LLP
Jan
29
2019
FDA Issues Final Guidance On Medical Device Safety And Performance-Based Pathway Barnes & Thornburg LLP
Dec
2
2014
Prosecutorial Over-Criminalization: Fishing for Guilty Pleas Barnes & Thornburg LLP
May
29
2019
FDA Issues Discussion Paper on Artificial Intelligence and Machine Learning in Medical Devices Barnes & Thornburg LLP
Feb
23
2015
FDA Issues Final Guidance Documents on Medical Device Data Systems and Medical Mobile Apps Barnes & Thornburg LLP
Sep
21
2015
FDA Publishes Final Rule on Preventive Controls for Human Food Barnes & Thornburg LLP
Sep
28
2023
SEC Staff Comment Asks Company for Quantitative Disclosure Related to Menu Price Impacts on Revenue Barnes & Thornburg LLP
Aug
22
2016
After 19 Years, FDA Issues Final Rule on GRAS Notices Barnes & Thornburg LLP
Aug
26
2016
FDA Updates Benefit-Risk Determinations for New Medical Devices Barnes & Thornburg LLP
Nov
14
2023
HHS-HRSA Terminates 340B Drug Pricing Program Registration Waiver Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins